Interaction of granulocyte colony-stimulating factor and high doses of liposomal amphotericin B in the treatment of systemic murine scedosporiosis
- 1 December 2004
- journal article
- research article
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 50 (4) , 247-251
- https://doi.org/10.1016/j.diagmicrobio.2004.07.011
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Efficacy of Albaconazole (UR-9825) in Treatment of DisseminatedScedosporium prolificansInfection in RabbitsAntimicrobial Agents and Chemotherapy, 2003
- Overview of the lipid formulations of amphotericin BJournal of Antimicrobial Chemotherapy, 2002
- Amphotericin B nephrotoxicityJournal of Antimicrobial Chemotherapy, 2002
- In Vitro Activities of Four Novel Triazoles against Scedosporium sppAntimicrobial Agents and Chemotherapy, 2001
- Immunotherapy in Patients with Systemic MycosesBioDrugs, 2001
- Treatment of orogastrointestinal candidosis in SCID mice with fluconazole alone or in combination with recombinant granulocyte colony-stimulating factor or interferon-?Medical Mycology, 2000
- Granulocyte Colony-Stimulating Factor and Azole Antifungal Therapy in Murine Aspergillosis: Role of Immune SuppressionAntimicrobial Agents and Chemotherapy, 1998
- Deep Infections Caused by Scedosporium prolificans: A Report on 16 Cases in Spain and a Review of the LiteratureMedicine, 1997
- Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitisMedical Mycology, 1997
- Clinical Resolution of Scedosporium prolificans Fungemia Associated with Reversal of Neutropenia Following Administration of Granulocyte Colony-Stimulating FactorClinical Infectious Diseases, 1996